Sign in to view content

APEX: A Phase II Randomized Clinical Trial Evaluating the Safety andPreliminary Efficacy of X-82 Administered Orally in the Treatment of Exudative AMD

Michael N. Cohen, MD

Video
Published 2020

Related

TIE2, VEGF, and Integrin Receptor Interplay and its Role in Retinal Disease
Peter K. Kaiser, MD FASRS
Updates from the Field
2020
Wet AMD 4 Symposium
Annual Meeting Talks
2020
Clinical Experience With the SCS Microinjector for Suprachoroidal Injections by Ophthalmologists
Milan Shah, MD
Annual Meeting Talks
2019

Category: Age-Related Macular Degeneration

See more